Preconditioning is a preventative approach, whereby minimized insults generate protection against subsequent larger exposures to the same or even different insults. In immune cells, endotoxin preconditioning downregulates the inflammatory response and yet, preserves the ability to contain infections. However, the protective mechanisms of preconditioning at the tissue level in organs such as the kidney remain poorly understood. Here, we show that endotoxin preconditioning confers renal epithelial protection in various models of sepsis in vivo. We also tested the hypothesis that this protection results from direct interactions between the preconditioning dose of endotoxin and the renal tubules. This hypothesis is on the basis of our previous findings that endotoxin toxicity to nonpreconditioned renal tubules was direct and independent of immune cells. Notably, we found that tubular protection after preconditioning has an absolute requirement for CD14-expressing myeloid cells and particularly, macrophages. Additionally, an intact macrophage CD14-TRIF signaling pathway was essential for tubular protection. The preconditioned state was characterized by increased macrophage number and trafficking within the kidney as well as clustering of macrophages around S1 proximal tubules. These macrophages exhibited increased M2 polarization and upregulation of redox and ironhandling molecules. In renal tubules, preconditioning prevented peroxisomal damage and abolished oxidative stress and injury to S2 and S3 tubules. In summary, these data suggest that macrophages are essential mediators of endotoxin preconditioning and required for renal tissue protection. Preconditioning is, therefore, an attractive model to investigate novel protective pathways for the prevention and treatment of sepsis. 26: 134726: -136226: , 201526: . doi: 10.1681 Gram-negative sepsis is a formidable and challenging clinical condition that carries very high morbidity and mortality. Indeed, it is estimated that mortality from sepsis can exceed 70%, especially when complicated by organ failure. 1 AKI is frequently seen in patients with sepsis and dramatically increases morbidity and mortality. To date, treatment of sepsis and sepsis-induced AKI remains supportive and relies primarily on antibiotic therapy, fluid and electrolyte management, and hemodynamic support. 2 One hallmark of sepsis is widespread tissue oxidative stress. Uncontrolled reactive oxygen species rapidly react with all biologic macromolecules and result in deleterious tissue damage, including organ failure. We and others have shown that the endotoxin (LPS) receptor Tolllike receptor 4 (TLR4) and coreceptor CD14 are expressed in renal tubules and upregulated in sepsis and ischemia. [3][4][5][6][7][8] We also showed that systemic endotoxin is freely filtered and interacts with S1
J Am Soc Nephrol